The experience of our team
The project involves the installation of a new aerosol production area of 1,100 m², with the manufacturing area of the reactors, primary packaging and secondary packaging, a sampling area and new weighing area with laminar flows and air treatment system, and control of all the facilities.
The Laboratories ERN SA is a Spanish pharmaceutical company which produces more than 20 active ingredients and 100 products (mostly for paediatric use, such as Apiretal or Citorsal), distributing around 15 million units, ranking it among the top 25 laboratories operating in Spain.
Laboratorios ERN SA is committed to a continuous extension of its product portfolio and the internationalisation of its medicines. The ambitious European project for the expansion of Apiretal under the Community trade mark Apiredol in several European countries is particularly outstanding. Also important are the various agreements for the export of medicines with active ingredients (parenteral fosfomycin, nitrofurantoin and amantadine) to European countries, the Americas, the Middle East and Africa.
The project led by Guillermo Galán involves the implementation of a new air treatment facility for the manufacturing room, primary packaging and secondary packaging. The air treatment installation includes the assembly of new air conditioning units, the new air distribution network and connection to the existing chilled water and hot water services. The combined installation is automated by a new system of control and management. Photos © ERN